Work

Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership

Year: 2017

Type: article

Abstract: The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood sample to identify early those patients whose cancer has returned, while analyzing circulating tumor cells (CTCs) in great detail, providing new clues on the most effective therapy for the patient's cancer.

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.657

Authors: C Dive, SN Shishido, P Kuhn

Institutions: University of Manchester, Cancer Research UK Manchester Institute, University of Southern California

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research UK, National Cancer Institute